Mammalian cells express two isoforms of eIF5A, eIF5A1 and eIF5A2, but little is known about the function of eIF5A2. Here we report that eIF5A2 is reversibly acetylated at lysine-47. HDAC6 and SIRT2 were identified as the enzymes responsible for deacetylating eIF5A2. Analysis using acetylation-deficient mutants indicated that acetylation regulates the subcellular localization of eIF5A2.
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Key words: eIF5A2; acetylation; hypusination; subcellular localization; HDAC Eukaryotic translation initiation factor 5A (eIF5A) is a small (approximately 17 kDa) acidic protein essential for cell growth. Yeast cells possess two eIF5A genes, TIF51A and TIF51B, encoding two isoforms, eIF5A1 and eIF5A2 respectively, either one of which can substitute for the other.
1) Mammals also possess two eIF5A genes, eIF5A1 and eIF5A2, with approximately 84% identity. eIF5A1 is ubiquitously expressed in all tissues and plays roles in translation elongation and RNA metabolism. On the other hand, eIF5A2 has been less well characterized. eIF5A2 shows tissue and celltype-specific expression. [2] [3] [4] In addition, it has been reported that overexpression of eIF5A2 promotes anchorage-independent cancer cell growth, tumor formation, cell motility, and metastasis, suggesting that it is an oncogene.
We previously raised an anti-acetylated eIF5A (AceIF5A) antibody to investigate eIF5A1 acetylation.
5)
Since this antibody is directed against the peptide conserved among both isoforms of eIF5A, it probably detects acetylation of eIF5A2 as well. Using this antibody, first we investigated to determine whether eIF5A2 is acetylated in cells treated with HDAC inhibitors (Fig. 1A) . The SW480 colorectal cancer cell line was chosen for this experiment in view of the expression of eIF5A2 in SW480, albeit at low levels as compared to eIF5A1. The cells were treated with three HDAC inhibitors, trichostatin A (TSA), nicotinamide (NA), and SCOP402, which bear different specificities. TSA inhibits all class I/II HDACs, whereas NA inhibits all class III enzymes and SCOP402 inhibits class I/II enzymes, except for HDAC6.
6) The cell lysates were collected after 16 h of incubation with the HDAC inhibitors, followed by immunoblot analysis. As expected, the acetylation of -tubulin, a substrate of HDAC6, dramatically increased in the cells treated with TSA, but not with NA or SCOP402 (Fig. 1A) , confirming the specificity of the HDAC inhibitors. Consistently with our previous report, 5) endogenous eIF5A1 acetylation was increased by treatment with TSA or NA, but not SCOP402, and simultaneous treatment with TSA and NA dramatically enhanced eIF5A1 acetylation (Fig. 1A) . In a similar way, acetylation of endogenous eIF5A2 was dramatically increased by simultaneous treatment with both TSA and NA (Fig. 1A) , suggesting that the eIF5A2 expressed in cancer cells undergoes reversible acetylation, and that multiple HDAC enzymes in classes I/II and III are involved in eIF5A2 deacetylation.
Next we tried to identify the histone deacetylases (HDACs) responsible for the deacetylation of eIF5A2. For this purpose, we expressed 10 major cellular deacetylase enzymes together with Flag-eIF5A2 in 293T cells (Fig. 1B and C) . Overexpression of HDAC6 and of SIRT2 alone but not of their catalytically dead mutants significantly reduced the acetylation level of eIF5A2, indicating that both HDAC6 and SIRT2 can deacetylate eIF5A2 in cells. Because HDAC6 is a TSAsensitive class II enzyme and SIRT2 is a class III enzyme that can be inhibited by NA, these results are consistent with the increased acetylation of endogenous eIF5A2 by simultaneous treatment with TSA and NA (Fig. 1A) .
Both eIF5A isoforms are known to be post-translationally modified with a hypusine, N"-(4-amino-2-y To whom correspondence should be addressed. Fax: +81-48-462-4676; E-mail: akihiro-i@riken.jp Biosci. Biotechnol. Biochem., 76 (11), [2165] [2166] [2167] 2012 Note hydroxybutyl) lysine, [7] [8] [9] at a specific lysine residue (lysine 50 for human eIF5A) by two consecutive enzymatic steps involving deoxyhypusine synthase (DHS) and deoxyhypusine hydroxylase (DOHH). 10) Importantly, hypusination is indispensable to the essential physiological function of eIF5A. In addition to hypusination at lysine 50, eIF5A1 is reversibly acetylated at lysine-47 and lysine-68. 11, 12) We found that acetylation at lysine-47 regulates the subcellular localization of eIF5A1. 5) Although the acetylation sites in eIF5A2 have not yet been determined, the hypusination and acetylation sites (lysine-50 and lysine-47 respectively) are highly conserved between the two isoforms of eIF5A and the sequences around these sites are identical, suggesting that lysine-47 of eIF5A2 is also a target for acetylation.
To test whether eIF5A2 can be acetylated at lysine 47, we overexpressed the Flag-tagged wild type, and the acetylation and hypusination site mutants (K47R and K50R respectively) of eIF5A2 in 293T cells. These cells do not endogenously express eIF5A2. The cell lysates obtained were immnunoblotted with anti-Ac-eIF5A, anti-Hyp-eIF5A, and anti-Flag antibodies. The slower mobility of Flag-eIF5A2 as compared to endogenous eIF5A1 allowed us to observe the acetylation and hypusination of both eIF5A isoforms simultaneously. The wild type and the K50R mutant of Flag-eIF5A2 were heavily acetylated, but the acetylation signal was completely lost in the K47R mutant, indicating that eIF5A2 is acetylated at lysine-47 ( Fig. 2A) . On the other hand, our anti-Hyp-eIF5A antibody detected only the hypusination of endogenous eIF5A1, and not exogenously expressed eIF5A2 ( Fig. 2A) . It has been reported that exogenously expressed eIF5A1 is largely unhypusinated, and can be hypusinated only when both DHS and DOHH are co-expressed. 13) Importantly, it has also been found that unhypusinated eIF5A1 expressed without DHS and DOHH is heavily acetylated at lysine-47, but is dramatically deacetylated upon hypusination, suggesting crosstalk between hypusination and acetylation. 13) To determine whether exogenously expressed eIF5A2 behaves in a similar manner, we overexpressed the wild type and a series of mutants of eIF5A2 along with DHS and DOHH expression in 293T cells. In the presence of DHS and DOHH, the hypusination signal was detected in the exogenously expressed eIF5A2 proteins, except the K50R mutant, which lacks the lysine residue for hypusination (Fig. 2B) , suggesting that eIF5A2 is hypusinated at lysine-50 as is eIF5A1. 14) Moreover, the acetylation of the K50R mutant was much greater than that of fully hypusinated wild-type eIF5A2 (Fig. 2B) , suggesting that hypusination also reduces acetylation in eIF5A2.
The acetylation status of eIF5A1 affects its subcellular distribution. 5) Due to the similarity of acetylation between the eIF5A isoforms, it is possible that eIF5A2 acetylation also plays a role in its subcellular local- ization. Hence we investigated the subcellular localization of eIF5A2 by expressing the Flag-tagged eIF5A2 wild type and the mutants in HeLa cells. As shown in Fig. 3 , unhypusinated wild-type Flag-eIF5A2 expressed in the absence of DHS/DOHH tended to localize to the nucleus. On the other hand, wild-type eIF5A2 was distributed in both the nucleus and the cytoplasm when hypusinated by DHS and DOHH, indicating that eIF5A2 is a shuttling protein. Importantly, a mutant incapable of being acetylated (K47R) was clearly localized to the cytoplasm in the presence of DHS and DOHH. In contrast, the subcellular distribution of a mutant mimicking acetylation (K47Q) was constitutively nuclear even after it was hypusinated by DHS and DOHH, suggesting that acetylation induces nuclear accumulation of eIF5A2. Similarly, K50R, which lacks the hypusination site, also showed nuclear localization, probably due to its hyperacetylation ( Fig. 2A and B) . These results suggest that the cytoplasmic localization of eIF5A2 requires hypoacetylation.
Taking into account our previous study, 5 ) reversible acetylation appears to be a common mechanism by which the subcellular localization of both eIF5A isoforms is regulated. Because a role of eIF5A2 in cancer development and metastasis has been recently reported, 3, 15, 16) the importance of eIF5A2 acetylation in its oncogenic properties should be elucidated in the near future. HeLa cells were transfected with the Flag-eIF5A2 wild type, acetylation site mutants (K47R and K47Q), and hypusination site mutant (K50R), along with pcDNA3-hDHS-HA and pcDNA3-hDOHH-Myc. The cells were fixed after 48 h of transfection and incubated with anti-FLAG antibody, and anti-HA antibody, followed by Alexa Fluor 488-conjugated secondary anti-mouse antibodies and Alexa Fluor 594-conjugated secondary anti-rabbit antibodies for detection of Flag-eIF5A2 and DHS-HA, respectively. Fluorescence was visualized through a Delta Vision microscope.
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